528
Participants
Start Date
April 27, 2020
Primary Completion Date
April 10, 2022
Study Completion Date
April 10, 2027
A: expander-silicone implant exchange and contralateral symmetrization with mastopexy and if needed with volume reduction
expander-silicone implant exchange and contralateral symmetrization with mastopexy and if needed with volume reduction
B: expander-silicone implant exchange with contralateral symmetrization with mastopexy and Ultrapro sling
expander-silicone implant exchange with contralateral symmetrization with mastopexy and Ultrapro sling
C: expander-silicone implant exchange and contralateral symmetrization with mastopexy and silicone implant augmentation
expander-silicone implant exchange and contralateral symmetrization with mastopexy and silicone implant augmentation
D: expander-silicone implant exchange and contralateral symmetrization with mastopexy and Utrapro sling and silicone implant augmentation
expander-silicone implant exchange and contralateral symmetrization with mastopexy and Utrapro sling and silicone implant augmentation
E: unilateral simple mastectomy
unilateral simple mastectomy
F: after bilateral SSM, ASM, NSM, expander-implant exchange
after bilateral SSM, ASM, NSM, expander-implant exchange
RECRUITING
National Institute of Oncology, Budapest
National Institute of Oncology, Hungary
OTHER